BK virus nephritis: risk factors, timing, and outcome in renal transplant recipients.
about
Evaluation of fluoroquinolones for the prevention of BK viremia after renal transplantationBK polyoma virus infection and renal disease in non-renal solid organ transplantationPolyomaviruses and disease: is there more to know than viremia and viruria?Leflunomide treatment for polyomavirus BK-associated nephropathy after kidney transplantation.Clinical aspects: focusing on key unique organ-specific issues of renal transplantation.Pre-transplant immune factors may be associated with BK polyomavirus reactivation in kidney transplant recipients.BK virus replication in patients with anti-neutrophil cytoplasmic antibody-associated vasculitis.Validation of noninvasive diagnosis of BK virus nephropathy and identification of prognostic biomarkers.BK Virus in Kidney Transplant Recipients: The Influence of Immunosuppression.Impact of HMG-CoA reductase inhibitors on the incidence of polyomavirus-associated nephropathy in renal transplant recipients with human BK polyomavirus viremiaAdaptive immunity rather than viral cytopathology mediates polyomavirus-associated nephropathy in mice.Urine cytology screening for polyoma virus infection following renal transplantation: the Oxford experienceDetection of BK virus in urine from renal transplant subjects by mass spectrometry.Polyomavirus-associated nephropathy: update in diagnosis.Polyomavirus-associated nephropathy: update of clinical management in kidney transplant patients.Developments in clinical islet, liver thoracic, kidney and pancreas transplantation in the last 5 years.Polyomavirus BK with rearranged noncoding control region emerge in vivo in renal transplant patients and increase viral replication and cytopathology.Epidemiology of BK virus in renal allograft recipients: independent risk factors for BK virus replication.Aggressive immunosuppression minimization reduces graft loss following diagnosis of BK virus-associated nephropathy: a comparison of two reduction strategies.Risk factors for polyoma virus nephropathyImmunity to Polyomavirus BK Infection: Immune Monitoring to Regulate the Balance between Risk of BKV Nephropathy and Induction of Alloimmunity.Polyomavirus-associated nephropathyHigh-level viruria as a screening tool for BK virus nephropathy in renal transplant recipientsAntirejection treatment in kidney transplant patients with BK viruria.HLA-A2, HLA-B44 and HLA-DR15 are associated with lower risk of BK viremia.Efficacy of levofloxacin in the treatment of BK viremia: a multicenter, double-blinded, randomized, placebo-controlled trialTransient versus persistent BK viremia and long-term outcomes after kidney and kidney-pancreas transplantation.Immunosuppressive agents as risk factors for BK virus nephropathy: an overview and update.The BK virus in renal transplant recipients-review of pathogenesis, diagnosis, and treatment.Monitoring and managing viral infections in pediatric renal transplant recipients.Everolimus: preventing organ rejection in adult kidney transplant recipients.Management of polyomavirus-associated nephropathy in renal transplant recipients.Obstructive uropathy is associated with polyomavirus viremia in pediatric kidney transplantation.Current problems in screening, diagnosis and treatment of polyomavirus BK nephropathy.Observations on the use of cidofovir for BK virus infection in renal transplantation.Evaluation of the predisposition and clinical impact of BK virus replication in kidney transplant patients.Clinical Pharmacokinetic Monitoring of Leflunomide in Renal Transplant Recipients with BK Virus Reactivation: A Review of the Literature.The efficacy of valganciclovir for prevention of infections with cytomegalovirus and Epstein-Barr virus after kidney transplant in children.Preferential accumulation of T helper cells but not cytotoxic T cells characterizes benign subclinical rejection of human liver allografts.BK Virus Nephropathy: Histological Evolution by Sequential Pathology.
P2860
Q24627138-B93122BD-D552-434E-980E-D5AEBA309A24Q26764877-837B2614-F937-4836-BD3E-674E690967E3Q28081350-0F1AEDF6-FFE3-426D-B752-2F073ECCA19FQ33376066-F962F09F-9F93-4E51-A453-E38118707F33Q33412327-228B37A9-AF07-47B8-BC03-9CF3822A7B82Q33745763-7B52EE04-6EA9-487E-AE0F-C1042A391B55Q34081869-5519D5A3-34A0-4D12-ACA4-BEA220739FFAQ34337472-F9EA5EEE-C6FE-4F7C-AD61-5845E38BC93DQ35099077-E8873B7E-5EA1-4A80-95C2-D9E60F5F99AAQ35930371-4B9BE29A-C697-4DB9-AB85-7C2090846A58Q36002505-383D1C68-2115-4077-BECD-EF79E831C0C5Q36014205-4CE34E67-BD2A-4BD8-A289-A94C015E2228Q36287065-17B7CD94-75E7-4E17-9129-5DE732D1E438Q36492403-6FA51D46-0440-438F-9DDC-718714C80BC9Q36492408-5813E224-DAD9-4A2A-8EE7-5F64064FFAA1Q36505718-E204EB90-A194-40FC-BE24-7858317418D1Q36537931-B9AFF994-BCFD-412C-A6E3-E73874D4BA4EQ36826101-04DA730C-8402-49A4-9A4A-4F4284F6F707Q36947285-5D49A263-2945-4200-9D73-763D212AA42EQ37102082-B15E0346-2698-453F-830A-4E47556E708DQ37127201-4FFF0748-29F6-4B8E-8D64-BA2BDE5B1D42Q37195470-3B43A056-CA44-4E14-884A-C49A1188D488Q37260167-2CA779A6-CA2A-4724-9C6E-EBD76C01FF4FQ37313492-E452B28F-6359-4B15-9EDE-3F6267E031EDQ37349698-CC800AD8-D397-4CDD-B0AF-E6315C684A56Q37621540-7D1FCEEC-6600-4333-8B11-5462654ABC0DQ37621575-7A882D65-A63B-45CD-9E4C-B88B6A2535E2Q37762535-E25D22E1-F7A2-48C2-83E2-C0DB32E14B98Q37821326-589373E3-2E65-45EF-801C-27D97C25D07FQ37848137-8B80C9F7-1628-45F0-B3B2-0BA5D71019FEQ37992135-8CB4EBE2-F3FC-48DF-AC82-9E7A3CF66CF6Q38003050-4F6637ED-6798-4AC3-8BD4-62A58D0C94C5Q38016973-A3738273-3648-4141-AC35-4C0D7775C20EQ38212983-94874131-5875-4BEE-91E5-09CF63A2D654Q38269958-FC4CDCB5-67BE-4C4A-9E7A-98D2CF769329Q38792824-B947892A-9F55-4EF9-ADCB-D590C03C6686Q39155699-0905C97C-0659-49A5-8EB1-6AB952BCD797Q39321579-FD2DA24E-D519-42F5-98DD-DFCBE914A327Q39957970-E824883B-A8B8-461F-A949-FF0742A1CFD0Q40260844-F43D6D48-0DA8-4E48-8432-D7F1FC3002FF
P2860
BK virus nephritis: risk factors, timing, and outcome in renal transplant recipients.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
BK virus nephritis: risk factors, timing, and outcome in renal transplant recipients.
@en
BK virus nephritis: risk factors, timing, and outcome in renal transplant recipients.
@nl
type
label
BK virus nephritis: risk factors, timing, and outcome in renal transplant recipients.
@en
BK virus nephritis: risk factors, timing, and outcome in renal transplant recipients.
@nl
prefLabel
BK virus nephritis: risk factors, timing, and outcome in renal transplant recipients.
@en
BK virus nephritis: risk factors, timing, and outcome in renal transplant recipients.
@nl
P2093
P1433
P1476
BK virus nephritis: risk factors, timing, and outcome in renal transplant recipients
@en
P2093
Barbara A Bresnahan
Brahm Vasudev
Eric P Cohen
Sundaram Hariharan
Yong-Ran Zhu
P304
P356
10.1111/J.1523-1755.2005.00602.X
P407
P577
2005-10-01T00:00:00Z
P5875
P6179
1004345623